Ramipril 2.5 mg Capsules
What this means
The MHRA has issued a medicines recall or defect notification. Class 1: risk to life, immediate recall. Class 2: may cause mistreatment or harm, recall within 48 hours. Class 3: unlikely to cause harm, recall within 5 days. Class 4 (defect notification): no recall, caution in use. The medicine remains licensed; only the listed batches are affected. Do not stop treatment without speaking to your doctor or pharmacist.
Class 2 recall · DMRC - 39617807
| Product | Licence | Active ingredient | GTIN |
|---|---|---|---|
| Ramipril 2.5 mg Capsules | PL 20416/0295 | ramipril | 05017123670138 |
Batches (expiry): GR155023 (08/2027)
Background: Crescent Pharma Limited is initiating a precautionary recall of one batch of Ramipril 2.5 mg Capsules following the identification of a potential packaging error at the manufacturing site. One complaint has been received to date, in which a sealed carton of Ramipril 2.5 mg Capsules (Batch No. GR155023) was found to contain two blister packs of Ramipril 10 mg Capsules (Batch No. GR175026). Both batches were manufactured at the same site, and the issue appears to have occurred during the secondary packaging process for Batch GR155023. Please note this is a Class 2 Patient, Pharmacy and Wholesaler level recall. Advice for Healthcare Professionals: